(Q44916829)

7 December 2017

title

Effect of gender on late-onset multiple sclerosis (English)

1 reference

7 December 2017

0 references

6

Tanuja Chitnis

1 reference

7 December 2017

Riley M Bove

1

1 reference

7 December 2017

Brian Healy

2

1 reference

7 December 2017

Ann Augustine

3

1 reference

7 December 2017

Alexander Musallam

4

1 reference

7 December 2017

Taha Gholipour

5

1 reference

7 December 2017

publication date

1 March 2012

1 reference

Multiple Sclerosis Journal

7 December 2017

published in

1 reference

7 December 2017

volume

18

1 reference

7 December 2017

issue

10

1 reference

7 December 2017

page(s)

1472-1479

1 reference

The prevalence of multiple sclerosis in the world: an update

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

The epidemiology of multiple sclerosis in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Age of puberty and the risk of multiple sclerosis: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Pregnancy and multiple sclerosis: the children of PRIMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Estrogen and testosterone therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Gender and sex hormones in multiple sclerosis pathology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Clinical predictors of early second event in patients with clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Parent-of-origin effect in multiple sclerosis: observations from interracial matings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Multiple sclerosis in childhood: clinical features of 149 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Multiple sclerosis in children under 10 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Late-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Is late-onset multiple sclerosis associated with a worse outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Multiple sclerosis with very late onset: report of six cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Multiple sclerosis with very late onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Brain MRI in late-onset multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Demographic and clinical characteristics of malignant multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

A proportional hazards model for interval-censored failure time data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Gene regulation and DNA damage in the ageing human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Estrogen treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Sex ratio of multiple sclerosis and clinical phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Prospective study of factors influencing the onset of natural menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Does multiple sclerosis-associated disability differ between races?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Genetics and pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Risk factors for and management of cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438236

21 January 2018

Identifiers

DOI

10.1177/1352458512438236

1 reference

7 December 2017

1 reference